The trajectory of base editing has been remarkable, progressing from the laboratory to patient care, treating debilitating or ...
A new training facility aimed at strengthening Ohio's biomanufacturing workforce will be located in New Albany. Earlier this ...
Directed by Kristoffer Borgli, the A24 film follows Emma, played by Zendaya, and Charlie, played by Pattinson, a happily ...
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
Beyond seizures: With experimental drug, Stoke aims to restore developmental loss in Dravet syndrome
Stoke Therapeutics is developing a drug designed to reduce seizures and restore some of their lost developmental function.
Wacker Chemie's 2025 report shows declining sales and earnings as the chemical giant launches cost-cutting measures to ...
As part of a larger review, analyst Leonid Timashev identified 13 companies that could see deal interest as well as more than ...
Protagonist Therapeutics will now sit back and collect cash from the J&J partnership, including an immediate $50 million ...
This clinical-stage biotech develops therapies targeting the root cause of cystic fibrosis, with a pipeline focused on CFTR ...
The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird ...
The Shenzhen, China-based biotech plans to launch a Phase I trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of IN026.
The latest biotech industry insights, including a publication demonstrating dramatic lifespan extension in aging mouse models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results